SMAD4 and hepatocellular carcinoma: In another example, miR-125b has been found to be negatively correlated with EMT phenotype and CSC marker expression in HCC specimens, and consequently, overexpression of miR-125b could attenuate the EMT phenotype in HCC cancer cells by targeting Smad2 and Smad4 (90).